HIGHLIGHTS
- who: September et al. from the University of Westminster, United Kingdom have published the paper: Ef cacy and safety of Abelmoschus moschatus capsules combined with tripterygium glycoside tablets on diabetic nephropathy: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: AM combined with TG and BT in the treatment of DN is the first systematic review and meta-analysis that has evaluated clinical efficacy and safety in comparison with AM and BT. Up to now, although there are many meta-analyses researching AM or TG on the treatment of DN, only one study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.